China Universal Asset Management Co., Ltd. - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 96 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15
+50.0%
1,455
+102.9%
0.00%
+33.3%
Q2 2023$10
+150.0%
717
+27.1%
0.00%
+200.0%
Q1 2023$4
-20.0%
564
+33.3%
0.00%
-50.0%
Q4 2022$5
-99.9%
423
+15.3%
0.00%0.0%
Q3 2022$4,0003670.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 4,901,358$41,368,0008.59%
Frazier Life Sciences Management, L.P. 5,827,415$49,183,0004.64%
Abingworth LLP 1,435,106$12,112,0003.88%
Penn Mutual Asset Management 86,940$734,0000.99%
683 Capital Management, LLC 1,440,000$12,153,0000.86%
Western Standard LLC 109,055$920,0000.70%
MPM BioImpact LLC 193,326$1,632,0000.45%
Newtyn Management, LLC 255,767$2,159,0000.41%
StepStone Group LP 422,085$3,562,0000.38%
Avidity Partners Management LP 1,919,800$16,203,0000.37%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders